In the 2015 Report on Tuberculosis Research Funding Trends released in November 2015 by TAG (Treatment Action Group), Singapore was reported to have spent more on TB R&D in 2014 as a percentage of its GDP than any other country or economy. Appearing in this report for the first time, Singapore gave USD 8.1 million to TB research in 2014, ranking higher than the much larger countries (and economies) of France, Switzerland, Australia, and Canada. The whole reported TB funding amount (USD 8.1 million) was awarded to SPRINT-TB, a TB research programme based in National University of Singapore.
The report points out that this can make a meaningful difference in TB R&D. Given the small base of available TB funding worldwide, an organization only needs to allocate more than USD 12 million per year to rank among the top 10 funders of TB R&D. Singapore thus has a tremendous potential to take a worldwide leadership position in TB R&D with SPRINT-TB as its flagship research programme.
TAG (Treatment Action Group) is an independent non-profit think tank of science-based treatment activists based in New York City, USA, which supports research to end tuberculosis epidemics. The Report on Tuberculosis Research Funding Trends, funded by the Stop TB Partnership, is published annually at the Union World Conference on Lung Health. The purpose of the report is to track TB research spending against the targets established by the Stop TB Partnership's Global Plan to Stop TB, 2011–2016.
TAG 2015 Report on Tuberculosis Research Funding Trends is available here.